RAINBOW was established with the aim of promoting the development of autologous bone marrow mesenchymal stem cell products
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 26, 2020 | Seed | ¥150M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hokkaido Research Institute for the Twenty-first Century | — | Seed |
Okasan Capital Partners | — | Seed |